Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Fish and Richardson
Covington
Colorcon
AstraZeneca
Federal Trade Commission
Fuji
Boehringer Ingelheim
Healthtrust

Generated: August 15, 2018

DrugPatentWatch Database Preview

Perindopril erbumine - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for perindopril erbumine and what is the scope of perindopril erbumine patent protection?

Perindopril erbumine is the generic ingredient in two branded drugs marketed by Symplmed Pharms Llc, Ani Pharms Inc, Apotex, Aurobindo Pharma, Lupin Ltd, and West-ward Pharms Int, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for perindopril erbumine. Six suppliers are listed for this compound.

Pharmacology for perindopril erbumine
Medical Subject Heading (MeSH) Categories for perindopril erbumine
Synonyms for perindopril erbumine
(2S,3(infinity)S,7(infinity)S)-1-[(S)-N-[(S)-1-Carboxybutyl]alanyl]hexahydro-2-indolinecarboxylic acid, 1-ethyl ester, compound with tert-butylamine (1:1)
(2S,3aS,7aS)-1-((S)-N-((S)-1-Carboxybutyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester, compound with tert-butylamine (1:1)
(2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)butyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylic acid tert-butylamine salt
(2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid; 2-methylpropan-2-amine
(2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid;2-methylpropan-2-amine
(2S,3aS,7aS)-1-{(2S)-2-[(1S)-1-(ethoxycarbonyl)butylamino]propanoyl}octahydro-1H-indole-2-carboxylic acid--2-methylpropan-2-amine (1/1)
(2S,3aS,7aS)-1-{(S)-2-[(S)-1-(ethoxycarbonyl)butylamino]propanoyl}octahydroindole-2-carboxylic acid--1,1-dimethylethanamine (1/1)
107133-36-8
133P368
1964X464OJ
1H-indole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydo-, (2S-(1R(R*(R*)),2alpha,3abeta,7abeta))_,compd. With 2-methyl-2-propanamine (1:1)
1H-Indole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-, (2S-(1(R*(R*)),2alpha,3abeta,7abeta))-, compd. with 2-methyl-2-propanamine (1:1)
2-methylpropan-2-amine (2S,3aS,7aS)-1-(((S)-1-ethoxy-1-oxopentan-2-yl)-L-alanyl)octahydro-1H-indole-2-carboxylate
AB0105687
AB2000130
AC-19078
AC1L9AYA
ACEON
Aceon (TN)
AK161702
AKOS015841351
AKOS015961912
AX8041142
C07707
C19H32N2O5.C4H11N
CAS-107133-36-8
CCG-39035
CHEBI:8025
CHEMBL1200343
Covapril
CP0070
CS-1904
D00624
DSSTox_CID_24198
DSSTox_GSID_44198
DTXSID1044198
HMS1922N07
HMS2093M06
HY-B0130A
IYNMDWMQHSMDDE-MHXJNQAMSA-N
KS-1243
LS-82690
McN-A-2833-109
MFCD02313824
MolPort-003-666-611
NCGC00178276-01
NCGC00357164-01
NSC-758929
NSC758929
Perindopril (erbumine)
Perindopril erbumine (JAN/USP)
Perindopril erbumine [USAN]
Perindopril erbumine, United States Pharmacopeia (USP) Reference Standard
Perindopril for peak identification, European Pharmacopoeia (EP) Reference Standard
Perindopril for stereochemical purity, European Pharmacopoeia (EP) Reference Standard
Perindopril tert-butylamine
Perindopril tert-butylamine, European Pharmacopoeia (EP) Reference Standard
Perindopril;Coversyl;Aceon
Pharmakon1600-01505212
S-9490-3
SCHEMBL41679
SPECTRUM1505212
ST24048892
TL8000252
Tox21_303915
UNII-1964X464OJ

US Patents and Regulatory Information for perindopril erbumine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin Ltd PERINDOPRIL ERBUMINE perindopril erbumine TABLET;ORAL 078263-003 Jan 27, 2010 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ani Pharms Inc PERINDOPRIL ERBUMINE perindopril erbumine TABLET;ORAL 078138-002 Nov 10, 2009 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Symplmed Pharms Llc ACEON perindopril erbumine TABLET;ORAL 020184-002 Dec 30, 1993 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for perindopril erbumine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Symplmed Pharms Llc ACEON perindopril erbumine TABLET;ORAL 020184-003 Dec 30, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Symplmed Pharms Llc ACEON perindopril erbumine TABLET;ORAL 020184-001 Dec 30, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Symplmed Pharms Llc ACEON perindopril erbumine TABLET;ORAL 020184-002 Dec 30, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Cipla
Boehringer Ingelheim
McKesson
Moodys
Deloitte
Citi
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.